Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Holding(s) in Company

TR-1: Standard form for notification of major holdings [][][][][][][]NOTIFICATION OFMAJOR HOLDINGS(to besent to the relevantissuer and tothe FCA in MicrosoftWord format ifpossible)[i] 1a. Identity of the EnQuest PLCissuer or theunderlying issuer ofexisting sharesto which votingrights areattached[ii]:1b. Please indicateif the issuer isa non-UK issuer (please mark withan "X" ifappropriate)Non-UK issuer2. Reason for thenotification (pleasemark theappropriate box orboxes with an"X")An acquisition or

Citycon to publish its Half-Yearly Report for January-June 2021 on Thursday, 5 August 2021 approximately at 9 am EEST

CITYCON OYJ   Investor News   29 July 2021 at 12:30 hrsCitycon will publish its Half-Yearly Report for 1 January – 30 June 2021 on Thursday, 5 August 2021 approximately at 9 am EEST. The report will be available on Citycon’s website immediately after publication.Citycon's investor, analyst and press conference call and live audiocasting will begin one hour later at 10 am EEST. The audiocast can be participated by calling in and followed live on the following website:  https://citycon.videosync.fi/2021-q2-resultsConference call numbers are:Participants from Europe +44 333 300 08 04

New data supporting targeting Trk receptors with ACD856 for the treatment of Alzheimer's disease presented at AAIC 2021

Stockholm, Sweden, July 29, 2021. AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that the company's presentation and poster regarding the clinical candidate drug ACD856 for Alzheimer's disease, presented at the Alzheimer's Association International Conference (AAIC) 2021 on July 26-30 in Denver, USA, are now available on the company's website.The abstract, titled ACD856 – a novel positive allosteric

poLight ASA – smartphone project mentioned in Q1-report cancelled due to portfolio changes, - the same OEM still express interest in TLens and other OEM has started evaluation

Horten, 29th July 2021 - poLight ASA (OSE: PLT) today announced that the company has been informed that the smartphone project mentioned in Q1 quarterly report has been cancelled. The plan was phone release to market in beginning of 2022 and start shipping TLens in Q4-2021. Reason for the cancellation is only related to portfolio strategy. The same OEM still express interest in TLens and will likely consider using TLens camera module for future smartphone releases. However, this is still to be decided. “As mentioned before timing and portfolio related decision is always a risk factor

Fetal development of the brain identified down to the smallest detail

Researchers at Karolinska Institutet in Sweden have developed a detailed molecular atlas of the fetal development of the brain. The study published in the top journal Nature is based on so-called single-cell technology and has been done on mice. In this way, researchers have identified almost 800 different cells that are active during fetal development – many times more than previously known."Brain development is well described and the main cell types are known. What is new about our atlas is the high resolution and detail," says Sten Linnarsson, head of research and professor at the

Vattenfall takes on direct marketing for 250 MW offshore wind farm Arcadis Ost 1 in the Baltic Sea

Vattenfall and Parkwind have agreed to cooperate in direct marketing[1] in the offshore wind power sector where Vattenfall will be marketing the Arcadis Ost 1 offshore windfarm in the Baltic Sea.The 250 MW offshore wind farm will be built 19 kilometers northeast of the island of Rügen in the Baltic Sea, in the coastal waters of Mecklenburg-West Pomerania. The construction phase is planned to begin in the second quarter of 2022. In total 27 wind turbines from the manufacturer MHI Vestas will come into operation. Parkwind expects that Arcadis Ost 1 will be able to feed the first wind power

AAK’s President and CEO has acquired additional shares in the company

Warrants in the long-term incentive program (“Warrants Program series 2017/2022:2”) implemented at AAK AB’s (publ.) annual general meeting in May 2017 has been possible to exercise since September 2020. President and CEO Johan Westman has exercised warrants and has at the same time acquired an additional 18,000 shares in AAK. He now has a total holding of 54,000 shares.For more information, please contact:Gabriella GrotteHead of IR and Corporate Communications Mobile: +46 737 16 80 01E-mail: gabriella.grotte@aak.com The information was submitted for publication at 10:10 a.m.

Elkem ASA – Grant of share options under share incentive scheme

Oslo, 29 July 2021 The board of directors of Elkem ASA ("Elkem" or the "Company", OSE ticker code: "ELK") has resolved to grant in total 7,350,000 share options to members of the management and certain other key employees under the Company's share incentive scheme. Each option gives the option holder the right to subscribe or purchase one share in the Company at an exercise price of NOK 31.20, which is equal to the average of the share price at closing on the first 20 working days of July 2021. The options will vest over a period of three years from grant with one-third vesting each

Invitation to press and analyst conference

Holmen’s interim report for January–June 2021 will be published at lunchtime on Thursday 19 August. In view of this, you are invited to watch the online broadcast of our press and analyst conference on the same day at 14.30 CEST. Time: 19 August at 14.30 CESTOnline broadcast: www.holmen.com/reports Holmen President and CEO Henrik Sjölund, together with CFO Anders Jernhall, will present and comment on the report. The presentation will be held in English. You may also participate in the conference by telephone, by calling: +46 8 519 993 83 (within Sweden)+44 333 300 9034 (from

Hydrogen – an increasingly important part of the green transition

The ongoing global discussion of how to solve energy storage, would find a great solution in hydrogen technology. – In my opinion, it is the only reasonable alternative, says Michael Glantz, CEO of myFC.At the same time, a green transition is taking place in the EU, where fossil-free hydrogen is an important part of solving the energy supply of the future, with the goal of achieving CO2 neutrality by 2050.One of the first things US President Joe Biden announced after taking the oath of office in January was a $ 2,000 billion stimulus investment where hydrogen is an important part.–

BillerudKorsnäs aims to divest the Beetham mill

BillerudKorsnäs is in a process with the aim of divesting the paper mill in Beetham, UK. The process is ongoing and no binding agreement to divest the mill has yet been entered into. Since BillerudKorsnäs’ machine glazed (MG) paper business has primarily been focused in Skärblacka, the strategic importance of Beetham to the rest of the group has been reduced.Beetham produces kraft paper for packaging of medical equipment, food packaging and other types of industrial applications and has a capacity of around 45 000 tonnes per year. In 2020, the facility had sales of around SEK 480 million.

Hammad Abuiseifan new CEO of Quickbit

Serod Nasrat has decided to resign from his role as CEO of Quickbit at his own request and the board has appointed Hammad Abuiseifan as new CEO. Serod Nasrat will continue to be active in the company, but in a different role.“Serod has successfully run Quickbit to the company it is today. Quickbit is now ready to take the next step in its development. The Board respects Serod's decision to resign from the role as CEO and we are pleased that he has chosen to continue within the company. We welcome Hammad Abuiseifan to take over from Serod, with the task of leading Quickbit in a new expansive

Biomaster protected Ammique beds supports Terra Carta for sustainable business

Ammique®, manufacturers of ‘the world’s most technologically advanced bed’ with Biomaster antimicrobial protection, has become an official supporter of Terra Carta , the charter that puts sustainability at the heart of the private sector. Launched by HRH The Prince of Wales on 11 January 2021, the Terra Carta lists 10 action articles for the decade towards an inclusive, prosperous and sustainable future. Ammique® has pledged to support the Terra Carta, its principles and action articles, which complement the company’s existing sustainability

Pharmacolog and Codonics® Expand Relationship

Pharmacolog and Codonics extend exclusive U.S. and Canadian distributor agreement to include DrugLog® in addition to WasteLog®In December 2020, Pharmacolog and Codonics entered into a distribution agreement, appointing Codonics as the exclusive distributor of WasteLog® in the U.S. and Canadian markets. The agreement is now expanded to include DrugLog® in both markets. DrugLog® is a robust and proven stand-alone solution for reducing errors in the drug administration process. In a few seconds, it can verify the identity and concentration of liquid pharmaceuticals in an instant, directly

New Boardmember Omnicar Holding AB

It is with great pleasure that we can announce that Kevin Magnussen has accepted to join the board of directors of Omnicar Holding AB.Magnussen who left Formula 1 at the end of 2020 is one of three ex-F1 drivers to be confirmed by Peugeot for their World Endurance Championship comeback. Claus T. Hansen, CEO of OmniCar Holding AB, says: “We are very excited about welcoming KM as a board member. KM has an outstanding reputation in the automotive industry. At a very young age his dedication, ambitions and hard work placed him among some of the best racing drivers in the world. KM has an

Finnair to offer an affordable corona testing near Helsinki Airport

Several EU countries require travellers to have a negative corona test as a requirement for entry. To make travel more accessible to more people, Finnair is now introducing a rapid antigen test that costs just 65 euros and is available from 4 August. Testing is handled by Finnair Health Services and it’s available at Finnair’s headquarters in Vantaa near the airport at Tietotie 9. The test can be booked online at finnairtest.mbooking.fi . The booking can be made with a Finnish personal identity code, or your date of birth. The test result and

ANNOUNCEMENT OF THE NAV OF THE P CAPITAL PARTNERS ALPHA

Stockholm, 29 July 2021 Since P Capital Partners Alpha decreased its contributed capital by SEK 28 million through a repayment to debenture holders and owners, the Net Asset Value of the P Capital Partners Alpha participation loan has been calculated. The Net Asset Value is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The repayment amounted to SEK 19,000 per participation loan debenture, and SEK 3 million to the owners. At the close of business on 28 July 2021, the Net Asset Value of the P Capital Partners Alpha

ANNOUNCEMENT OF THE NAV OF P CAPITAL PARTNERS III

Stockholm, 29 July 2021 Since Proventus Capital Partners III decreased its contributed capital by SEK 288 million through a repayment to debenture holders and owners, the Net Asset Value of the P Capital Partners III participation loan has been calculated. The Net Asset Value is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The repayment amounted to SEK 25,000 per Series A participation loan debenture, SEK 625,000 per Series B participation loan debenture and SEK 32 million to the owners. At the close of business on 28 July

Broad scope of Wärtsilä solutions selected for OHT’s next-generation wind turbine installation vessel

Wärtsilä Corporation, Press release, 29 July 2021 at 10:00 AM EESTThe technology group Wärtsilä has been selected to supply an integrated propulsion and dynamic positioning thruster solution, including the engines, a Wärtsilä NOx reducer emission abatement system , as well as steerable  and tunnel thrusters  to deliver optimum performance for vessel dynamic positioning in this new wind turbine installation vessel (WTIV). The ship is being built at the China Merchants Heavy Industry (Jiangsu) Co yard for

Securitas acquires leading electronic security company in Germany

Securitas, the world’s leading intelligent protective services partner, has agreed to acquire Protection One, the German market leader specializing in remote technology-driven security solutions and electronic security. The acquisition will enhance Securitas’ protective services capabilities in Germany and is in line with the Group’s strategy of doubling its security solutions and electronic security sales by 2023. The purchase price is approximately MEUR 72 (MSEK 735) on a debt-free basis.In 2020, Protection One’s annual sales were more than MEUR 33 (MSEK 337), of which over 90 percent

Dustin's Board of Directors resolves on a rights issue of approximately SEK 1,200 million

The information in this press release is not intended for publication, public release or distribution, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Singapore or any other jurisdiction where such publication or distribution would violate applicable laws or regulations. See the section "Important information" at the end of this press release. The Board of Directors of Dustin Group AB (publ) ("Dustin" or the "Company") has today, making use of the authorisation by the Extraordinary General Meeting on May 18, 2021, resolved on a rights issue of no more

MPC Container Ships ASA refinances term loans with USD 70 million revolving credit facility

Oslo, 29 July 2021 – MPC Container Ships ASA (the "Company", together with its subsidiaries the "Group") is pleased to announce that it has entered into a USD 70 million three-year revolving credit facility agreement with CIT Group at attractive terms. An initial drawdown of USD 40 million has been used to refinance existing debt. As a consequence, the previous term loans with Beal Bank and CIT have been repaid in full. Further drawdowns under the facility will strengthen the free liquidity and may be used for vessel upgrades, investments or general corporate purposes. CEO Constantin

2cureX appoints two internationally highly recognized oncologists as Clinical Advisors

2cureX AB, a company pioneering the use of 3D microtumors in designing efficacious cancer treatment for the individual patient, announced today that Dr. John Lindsay Marshall, from Georgetown University Hospital, Washington DC, US and Dr Jesús García-Foncillas, from University Hospital Fundación Jimenez Diaz, Madrid, Spain have joined 2cureX Clinical Advisory Board.“2cureX is honored that Dr. John L. Marshall and Dr. Jesús García-Foncillas have accepted to assist us in defining the next generation of personalized oncology tools based on the IndiTreat® test. Not only will 2cureX benefit from

There are no items matching the current filter
There are no more items matching the current filter
Back to top